CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER ...Middle East

WESTON, Fla., Dec. 9, 2024 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions, announced today that the U.S. Food and Drug Administration (FDA)...

Read More Details
Finally We wish PressBee provided you with enough information of ( CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER )

Also on site :

• Vacaville carjacking suspects arrested in Fairfield; suspect shot by police
• ‘80s Music Icon Poses Nude to Celebrate Her 67th Birthday
• See photos of Jeff Bezos spanking bride-to-be Lauren Sánchez while lounging on $500M superyacht